Skip to Content
Morningstar

WisdomTree Europe Quality Div Gr ETF EUDG

Morningstar Medalist Rating
Medalist Rating as of | See WisdomTree Investment Hub

Morningstar’s Analysis EUDG

Will EUDG outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable EUDG’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the EUDG management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of EUDG’s parent organization’s priorities and whether they’re in line with investors’ interests.

WisdomTree Europe Quality Div Gr ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings EUDG

More EUDG Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 34.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Lvmh Moet Hennessy Louis Vuitton SE

4.65 3.1 Mil
Consumer Cyclical

Nestle SA

4.07 2.7 Mil
Consumer Defensive

Industria De Diseno Textil SA Share From Split

3.97 2.7 Mil
Consumer Cyclical

Unilever PLC

3.77 2.5 Mil
Consumer Defensive

Novartis AG Registered Shares

3.74 2.5 Mil
Healthcare

Roche Holding AG

3.22 2.2 Mil
Healthcare

Deutsche Telekom AG

3.17 2.1 Mil
Communication Services

Sanofi SA

2.65 1.8 Mil
Healthcare

AstraZeneca PLC

2.64 1.8 Mil
Healthcare

ASML Holding NV

2.62 1.8 Mil
Technology